Powered by
ANN ARBOR–The biotech startup Akadeum Life Sciences announced the successful close of a $20 million+ financing round, led by Grand Rapids-based Michigan Capital Network, with participation from Ann Arbor-based Arboretum …
ANN ARBOR–Lynx Dx announced publication of a comprehensive analytical validation study of its flagship test, MyProstateScore 2.0, in the peer-reviewed journal Diagnostics. The results confirm the test’s strong analytical performance …
GROSSE POINTE FARMS–SciTech Development Inc., a clinical-stage oncology drug development company, announced that the U.S. Food and Drug Administration has approved its Investigational New Drug (IND) application for a Phase …
GROSSE POINTE FARMS—SciTech Development LLC, a clinical-stage pharmaceutical company specializing in oncology, announced the initiation of the next stage of its clinical trial for their lead drug candidate, ST-001 nanoFenretinide. …
ANN ARBOR–Lynx Dx, developing diagnostic technology for prostate cancer, announced that its MyProstateScore 2.0 (MPS2) has been approved for coverage from Medicare, effective Sept. 11, following a successful technical assessment …
ANN ARBOR–Endra Life Sciences Inc. (NASDAQ: NDRA), developers of Thermo Acoustic Enhanced UltraSound (TAEUS) medical imaging technology, reported a loss of $2.4 million for the third quarter ended Sept. 30, …
ANN ARBOR—The autoimmune disease pharma startup Evoq Therapeutics announced it had received a $2 million grant from the National Institutes of Health to advance novel therapies for autoimmune diseases. “We …
ANN ARBOR—The medical device startup ENDRA Life Sciences Inc. (NASDAQ: NDRA) announced that on Aug. 27, the company received word from Nasdaq Stock Market LLC that the Nasdaq Hearings Panel …
DETROIT–Karmanos Cancer Institute announced that it will be the first provider in the country to offer patients the new FDA-approved TheraBionic P1 device for the treatment of advanced hepatocellular carcinoma …
DETROIT–Alerje Inc., developers of new products for emergency medicine and food allergy management announced a Phase II grant award from the Small Business Innovation Research program of the National Science …